Rare diseases
Investigational molecules
Locations
Back to Germany3 clinical trials in Wolfenbüttel, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials exploring the combination of neoadjuvant chemotherapy with immunotherapy agents for treating early-stage breast cancer patients. The research focuses on improving treatment outcomes through targeted therapeutic approaches.
These studies aim to enhance treatment efficacy in breast cancer therapy through novel drug combinations.
Advanced research evaluating Sacituzumab Govitecan compared to standard treatment options for HER2-negative breast cancer patients. The studies focus on patients with high relapse risk following standard neoadjuvant treatment.
This research aims to establish more effective treatment protocols for high-risk breast cancer patients.
Comprehensive investigation of Ribociclib efficacy in hormone receptor-positive, HER2-negative breast cancer. The research examines spatial and temporal patterns in treatment response for first-line therapeutic applications.
The study aims to understand treatment patterns and improve outcomes in advanced breast cancer cases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
